← Leaderboards
Richard Klinghoffer
Presage Biosciences, Inc.
$2,260,561
Attributed
$3,288,692
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–18$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,288,692 · 2
By mechanism
R44$3,000,000 · 1
R43$288,692 · 1
Top collaborators
- James M Olson2 shared
Others in their field
Top investigators on “Oncology”
- Larry Arthur$365,424,300
- David Heimbrook · Leidos Biomedical Research, Inc.$284,312,591
- Gregory H Reaman · National Childhood Cancer Foundation$243,308,665
- Norman Wolmark · Nsabp Foundation, Inc.$233,216,600
- Charles A Coltman · Southwest Oncology Group$199,580,977
- Peter C Adamson · National Childhood Cancer Foundation$192,690,226
Research focus
OncologyTechnologyIn VitroNeoplastic CellPharmaceutical PreparationsResistanceDrug ResistanceHandMalignant NeoplasmsMicroinjectionsPathway InteractionsCancer CellPharmacologic SubstancePublic Health RelevanceCancer PatientClinical TrialsExposure ToCellsCost EffectiveIn VivoMedicineClinicDrug CombinationsTumor
Grant awards (5)
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma$943,738
R44 · FY2018 · CA · contact PI
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma$1,002,741
R44 · FY2017 · CA · contact PI
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma$1,053,521
R44 · FY2016 · CA · contact PI
Gene traps and in vivo microinjection: a cancer drug discovery platform$143,975
R43 · FY2014 · CA · contact PI
Gene traps and in vivo microinjection: a cancer drug discovery platform$144,717
R43 · FY2013 · CA · contact PI